Wael Fayad, MBA is a Co-Founder of ACCOY Pharmaceuticals and serves as a Director on ACCOY's Strategy Advisory Board. Prior to ACCOY, he was the Corporate Vice President, Global Business Development for Forest Laboratories, Inc. until Forest was purchased by Actavis for $28 billion. During his 14 years at Forest, as a member of the senior management team, he was involved in setting strategic direction with respect to pipeline, disease areas and geographies. Under his leadership, the business development group completed transactions that represented 30% of Forest’s revenues. His business development group sourced, assessed, and triaged roughly 400 opportunities, submitted 10-15 term sheets, and signed 3-5 transactions annually. Prior to Forest, he held various portfolio management, brand management, market research, and sales positions with Schering-Plough and Sandoz/Novartis. He received his Masters of Business Administration from Concordia University in Montreal, Canada and his Bachelor of Science in Biology from the American University of Beirut, Lebanon.
Director, Strategy Advisory Board